These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28441649)

  • 1. Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive Subtypes.
    Cerff B; Maetzler W; Sulzer P; Kampmeyer M; Prinzen J; Hobert MA; Blum D; van Lummel R; Del Din S; Gräber S; Berg D; Liepelt-Scarfone I
    Neurodegener Dis; 2017; 17(4-5):135-144. PubMed ID: 28441649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.
    Glonnegger H; Beyle A; Cerff B; Gräber S; Csoti I; Berg D; Liepelt-Scarfone I
    J Alzheimers Dis; 2016 Jul; 53(4):1475-84. PubMed ID: 27392856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.
    Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I
    J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Tkaczynska Z; Sulzer P; Timmers M; Van Nueten L; Salvadore G; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    Neuropsychology; 2020 May; 34(4):447-455. PubMed ID: 32191056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia.
    Matteau E; Dupré N; Langlois M; Provencher P; Simard M
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):100-6. PubMed ID: 22689702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidomain cognitive training increases physical activity in people with Parkinson's disease with mild cognitive impairment.
    Bode M; Sulzer P; Schulte C; Becker S; Brockmann K; Elben S; Folkerts AK; Ophey A; Schlenstedt C; Witt K; Wojtecki L; Evers J; Maetzler W; Kalbe E; Liepelt-Scarfone I
    Parkinsonism Relat Disord; 2023 Aug; 113():105330. PubMed ID: 36842867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment.
    Simon-Gozalbo A; Rodriguez-Blazquez C; Forjaz MJ; Martinez-Martin P
    Front Neurol; 2020; 11():731. PubMed ID: 32849203
    [No Abstract]   [Full Text] [Related]  

  • 13. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Multiple Object Test as a performance-based tool to assess the decline of ADL function in Parkinson's disease.
    Beyle A; Glonnegger H; Cerff B; Gräber S; Berg D; Liepelt-Scarfone I
    PLoS One; 2018; 13(8):e0200990. PubMed ID: 30067788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Function and Quality of Life in Parkinson's Disease: A Cross-Sectional Study.
    Tang Y; Liang X; Han L; Peng F; Shen B; Yu H; Shen Y; Shen C; Yu J; Wang J
    J Parkinsons Dis; 2020; 10(3):1209-1216. PubMed ID: 32568115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
    Domellöf ME; Ekman U; Forsgren L; Elgh E
    Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.
    Oh Y; Kim JS; Lyoo CH; Park G; Kim H
    Neurology; 2024 Jul; 103(2):e209498. PubMed ID: 38885485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COWAT Performance of Persons with Alzheimer Dementia, Vascular Dementia, and Parkinson Disease Dementia According to Stage of Cognitive Impairment.
    Lim KB; Kim J; Lee HJ; Yoo J; Kim HS; Kim C; Lee H
    PM R; 2019 Jul; 11(7):737-744. PubMed ID: 30746867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.